Danaher Co. (DHR) Holdings Boosted by State of Alaska Department of Revenue

State of Alaska Department of Revenue boosted its holdings in Danaher Co. (NYSE:DHR) by 289.6% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 66,724 shares of the conglomerate’s stock after buying an additional 49,596 shares during the quarter. State of Alaska Department of Revenue’s holdings in Danaher were worth $6,192,000 at the end of the most recent quarter.

A number of other large investors have also modified their holdings of the business. Vanguard Group Inc. raised its position in Danaher by 1.3% in the 2nd quarter. Vanguard Group Inc. now owns 41,488,407 shares of the conglomerate’s stock worth $3,501,206,000 after buying an additional 520,776 shares during the last quarter. BlackRock Inc. raised its position in Danaher by 3.2% in the 2nd quarter. BlackRock Inc. now owns 39,201,798 shares of the conglomerate’s stock worth $3,308,239,000 after buying an additional 1,233,876 shares during the last quarter. FMR LLC raised its position in Danaher by 0.9% in the 2nd quarter. FMR LLC now owns 19,624,350 shares of the conglomerate’s stock worth $1,656,100,000 after buying an additional 183,183 shares during the last quarter. Parnassus Investments CA raised its position in Danaher by 0.3% in the 3rd quarter. Parnassus Investments CA now owns 9,796,584 shares of the conglomerate’s stock worth $840,351,000 after buying an additional 29,381 shares during the last quarter. Finally, Flossbach Von Storch AG raised its position in Danaher by 17.2% in the 3rd quarter. Flossbach Von Storch AG now owns 6,776,921 shares of the conglomerate’s stock worth $581,324,000 after buying an additional 994,902 shares during the last quarter. 76.11% of the stock is owned by institutional investors and hedge funds.

A number of equities analysts have weighed in on DHR shares. Citigroup boosted their target price on Danaher to $107.00 and gave the stock a “buy” rating in a research report on Friday, December 15th. Robert W. Baird reaffirmed a “buy” rating on shares of Danaher in a research report on Friday, January 12th. Goldman Sachs Group reaffirmed a “neutral” rating and set a $83.00 price target on shares of Danaher in a research report on Tuesday, September 26th. Royal Bank of Canada reaffirmed a “hold” rating and set a $96.00 price target on shares of Danaher in a research report on Thursday, January 4th. Finally, Credit Suisse Group upped their price target on shares of Danaher from $93.00 to $96.00 and gave the company an “outperform” rating in a research report on Friday, October 20th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the company. Danaher presently has a consensus rating of “Buy” and a consensus price target of $95.86.

In related news, SVP Daniel Raskas sold 37,870 shares of the stock in a transaction that occurred on Thursday, November 16th. The shares were sold at an average price of $93.33, for a total value of $3,534,407.10. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CAO Robert S. Lutz sold 11,189 shares of the stock in a transaction that occurred on Monday, October 23rd. The stock was sold at an average price of $91.66, for a total transaction of $1,025,583.74. Following the completion of the sale, the chief accounting officer now directly owns 18,314 shares of the company’s stock, valued at $1,678,661.24. The disclosure for this sale can be found here. Insiders sold a total of 273,810 shares of company stock valued at $25,218,813 over the last three months. 12.20% of the stock is currently owned by insiders.

Shares of Danaher Co. (DHR) opened at $100.56 on Friday. Danaher Co. has a 52-week low of $78.97 and a 52-week high of $100.88. The company has a market cap of $69,950.03, a PE ratio of 29.66, a PEG ratio of 2.18 and a beta of 1.02. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.00 and a current ratio of 1.43.

Danaher (NYSE:DHR) last released its earnings results on Thursday, October 19th. The conglomerate reported $1.00 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.95 by $0.05. The company had revenue of $4.53 billion during the quarter, compared to analyst estimates of $4.47 billion. Danaher had a net margin of 13.36% and a return on equity of 11.29%. The firm’s quarterly revenue was up 9.6% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.87 EPS. sell-side analysts expect that Danaher Co. will post 3.99 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, January 26th. Investors of record on Friday, December 29th will be issued a $0.14 dividend. This represents a $0.56 annualized dividend and a yield of 0.56%. The ex-dividend date is Thursday, December 28th. Danaher’s dividend payout ratio is 16.52%.

COPYRIGHT VIOLATION NOTICE: This article was first posted by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are viewing this article on another publication, it was stolen and reposted in violation of US and international copyright law. The original version of this article can be viewed at https://ledgergazette.com/2018/01/21/danaher-co-dhr-holdings-boosted-by-state-of-alaska-department-of-revenue.html.

About Danaher

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply